Establish provisions for the regulation of certain products derived from industrial hemp.
Impact
The bill's provisions are designed to impose strict labeling requirements on hemp products, ensuring that consumers are informed about the contents and potential health risks associated with these products. Labels must disclose testing results, ingredients, allergens, and a nutritional fact panel. These measures aim to enhance consumer awareness and safety, while also potentially increasing the legitimacy and accountability of the industrial hemp sector within the state. However, any violations of these labeling requirements would be classified as a Class 1 misdemeanor, emphasizing the serious implications for non-compliance.
Summary
House Bill 1164 introduces regulations for products derived from industrial hemp in South Dakota. The legislation mandates that the Department of Health establish rules that will set testing protocols for hemp products intended for human consumption, specifically those derived using isomerization or acetylation processes. This includes establishing certification standards for laboratories, testing requirements for cannabinoid content, and safety assessments against various harmful substances including microbials, mycotoxins, and pesticides. The intent behind these safety measures is to ensure that consumers are adequately protected and that the products available in the market are both safe and reliable.
Contention
Debate around HB 1164 may arise due to the regulations impacting businesses involved in the hemp industry. Supporters of the bill argue that such regulations are necessary to ensure consumer safety and to build trust in hemp-derived products, which have gained significant popularity in recent years. However, there may be concerns from producers regarding the potential burden imposed by stringent testing and labeling requirements, which could complicate production processes and increase operational costs. The balance between consumer protection and business viability is likely to be a focal point in discussions surrounding the bill.
To provide for the regulation of industrial hemp, industrial hemp products, and industrial hemp-derived cannabidiol (CBD) products (EN INCREASE GF EX See Note)
Prohibiting the transfer of hemp-derived cannabinoid products to any person under the age of 21, establishing packaging and labeling requirements for such products and amending the definition of industrial hemp and hemp products.